FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial
Shuying S. Li(Fred Hutch Cancer Center), Daniel E. Geraghty(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), David C. Montefiori(Duke University), Raphaël Gottardo(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Heather A. Prentice(The Medical Device (United Kingdom)), Michael D. Alpert(Harvard University Press), Paul T. Edlefsen(Fred Hutch Cancer Center), Daryl E. Morris(Fred Hutch Cancer Center), James Y. Dai(Fred Hutch Cancer Center), Georgia D. Tomaras(National Institutes of Health), Nelson L. Michael(Walter Reed Army Institute of Research), Abraham Pinter(Rutgers, The State University of New Jersey), Susan Zolla‐Pazner(Icahn School of Medicine at Mount Sinai), Nicole Frahm(Fred Hutch Cancer Center), Guido Ferrari(Duke University), Holly Janes(Fred Hutch Cancer Center), Barton F. Haynes(Duke University), Punnee Pitisuttithum(Mahidol University), Gary J. Nabel(National Institutes of Health), Rasmi Thomas(Walter Reed Army Institute of Research), Jaranit Kaewkungwal(Mahidol University), Robert J. O’Connell(Walter Reed Army Institute of Research), Youyi Fong(Fred Hutch Cancer Center), Sorachai Nitayaphan(Royal Thai Army), Gustavo H. Kijak(Walter Reed Army Institute of Research), Merlin L. Robb(University of Maryland, Baltimore), M. Juliana McElrath(Fred Hutch Cancer Center), Peter B. Gilbert(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Fusheng Li(Shanghai Jiao Tong University), Supachai Rerks‐Ngarm(Ministry of Public Health), Hua-Xin Liao(Duke University), Jérôme H. Kim(International Vaccine Institute), Chul-Woo Pyo(Fred Hutch Cancer Center), David T. Evans(University of Wisconsin–Madison)
Cited by 109
Related Papers
Integrated analysis of multimodal single-cell data
|Cell|2021|16.2k
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS
|Science|1984|3.6k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k